title: The wearable cardioverter-defibrillator: current technology and evolving indications.
abstract: The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable cardioverter-defibrillator. The use of the wearable cardioverter-defibrillator is included in the new 2015 ESC guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death. The present review provides insight into the current technology and an overview of this approach.
authors.affiliation: Electrophysiology Service, Hirslanden Klinik Aarau, Aarau, Switzerland.|Rhythmologie Aargau, Rain 34, CH-5000 Aarau, Switzerland.
authors.forename: Sven
authors.initials: S
authors.lastname: Reek
authors.affiliation: Cardiology Service, University Hospital of Geneva, Geneva, Switzerland.
authors.forename: Haran
authors.initials: H
authors.lastname: Burri
authors.affiliation: Cardiac Rhythm Management, University Hospital Southampton, Southampton, UK.
authors.forename: Paul R
authors.initials: PR
authors.lastname: Roberts
authors.affiliation: Cardiology, St Marien Hospital Luenen, Luenen, Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Perings
authors.affiliation: Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Andrew E
authors.initials: AE
authors.lastname: Epstein
authors.affiliation: University of Rochester Medical Center, Heart Research Follow up Program, Rochester, NY, USA.
authors.forename: Helmut U
authors.initials: HU
authors.lastname: Klein
authors.forename: Gregory
authors.initials: G
authors.lastname: Lip
authors.forename: Bulent
authors.initials: B
authors.lastname: Gorenek
authors.forename: Christian
authors.initials: C
authors.lastname: Sticherling
authors.forename: Laurent
authors.initials: L
authors.lastname: Fauchier
authors.forename: Andreas
authors.initials: A
authors.lastname: Goette
authors.forename: Werner
authors.initials: W
authors.lastname: Jung
authors.forename: Marc A
authors.initials: MA
authors.lastname: Vos
authors.forename: Michele
authors.initials: M
authors.lastname: Brignole
authors.forename: Christian
authors.initials: C
authors.lastname: Elsner
authors.forename: Gheorghe-Andrei
authors.initials: GA
authors.lastname: Dan
authors.forename: Francisco
authors.initials: F
authors.lastname: Marin
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Boriani
authors.forename: Deirdre
authors.initials: D
authors.lastname: Lane
authors.forename: Carina
authors.initials: C
authors.lastname: Blomström-Lundqvist
authors.forename: Irina
authors.initials: I
authors.lastname: Savelieva
mesh_terms: D001145:Arrhythmias, Cardiac / Q000191:economics / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D003362:Cost-Benefit Analysis; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D047548:Defibrillators / Q000191:economics; D004059:Diffusion of Innovation; D004554:Electric Countershock / Q000009:adverse effects / Q000191:economics / Q000295:instrumentation* / Q000401:mortality; D004867:Equipment Design; D017048:Health Care Costs; D006801:Humans; D010349:Patient Compliance; D017060:Patient Satisfaction; D012307:Risk Factors; D016896:Treatment Outcome
keywords: External defibrillation; Life vest; Sudden cardiac death; Ventricular arrhythmias; Wearable cardioverter-defibrillator